HKSTP, Merck launch incubation programme for biomedical tech startups

The collaboration will last three years.

The Hong Kong Science and Technology Parks Corporation (HKSTP) has partnered with pharmaceutical firm Merck to launch a co-incubation programme aimed at accelerating the growth of biomedical tech startups engaged in digital health solutions.

HKSTP and Merch will open up new research & development opportunities for startups, with the goal of bringing “innovative digital solutions including but not limited to digital therapeutics, digital wearable device and AI drug discovery and development, to address unmet medical needs,” according to a joint press announcement.

The collaboration will last three years and is expected to pave the way for startups to rapidly commercialise digital health products by leveraging the full capacity of HKSTP’s ecosystem and Merck’s extensive investor and strategic partner network.

Merck said that it will also provide deep industry insight and help connect promising startups to Merck’s Innovation Hub strategic partners and business units to explore market opportunities in emerging markets.